Stock Scorecard



Stock Summary for Orasure Technologies Inc (OSUR) - $2.74 as of 1/16/2026 2:19:36 PM EST

Total Score

13 out of 30

Safety Score

15 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for OSUR

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for OSUR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for OSUR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for OSUR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for OSUR (15 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for OSUR

The Truth About OraSure Technologies: Is This ‘Boring’ Test Maker Your Next Viral Money Play? 1/16/2026 3:57:00 PM
Altai pushes OraSure (NASDAQ: OSUR) board shakeup with two nominees at 2026 annual meeting 1/16/2026 11:57:00 AM
Altai Capital nominates two directors for OraSure Technologies board By Investing.com 1/16/2026 5:58:00 AM
Altai Capital nominates two directors to OraSure board amid concerns By Investing.com 1/16/2026 5:58:00 AM
5.2% OraSure shareholder pushes new directors with AI, tech focus 1/15/2026 11:57:00 PM
Altai Capital nominates two directors for OraSure Technologies board By Investing.com 1/15/2026 6:32:00 PM
New leadership duo joins IAS to steer global digital ad quality push 1/15/2026 5:32:00 PM
Altai Capital nominates two directors to OraSure's board (update) (OSUR:NASDAQ) 1/15/2026 3:32:00 PM
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors 1/15/2026 1:32:00 PM
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital 1/15/2026 1:00:00 PM

Financial Details for OSUR

Company Overview

Ticker OSUR
Company Name Orasure Technologies Inc
Country N/A
Description OraSure Technologies, Inc. (OSUR) is a leading innovator in oral fluid diagnostic solutions and sample collection devices, focused on enhancing global health outcomes through advanced diagnostic testing for infectious diseases and biosurveillance. Headquartered in Bethlehem, Pennsylvania, the company leverages its cutting-edge technologies and strong international presence to address pressing public health challenges. By continuously expanding its diverse product portfolio and establishing strategic partnerships, OraSure is well-positioned to capitalize on emerging growth opportunities in the rapidly evolving diagnostics market.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 9/30/2025
Next Earnings Date 2/24/2026

Stock Price History

Last Day Price 2.74
Price 4 Years Ago 4.82
Last Day Price Updated 1/16/2026 2:19:36 PM EST
Last Day Volume 311,205
Average Daily Volume 650,054
52-Week High 4.22
52-Week Low 2.08
Last Price to 52 Week Low 31.73%

Valuation Measures

Trailing PE N/A
Industry PE 42.91
Sector PE 54.65
5-Year Average PE -12.14
Free Cash Flow Ratio 0.91
Industry Free Cash Flow Ratio 30.90
Sector Free Cash Flow Ratio 28.78
Current Ratio Most Recent Quarter 7.03
Total Cash Per Share 3.02
Book Value Per Share Most Recent Quarter 5.01
Price to Book Ratio 0.52
Industry Price to Book Ratio 3.37
Sector Price to Book Ratio 43.34
Price to Sales Ratio Twelve Trailing Months 1.57
Industry Price to Sales Ratio Twelve Trailing Months 132.08
Sector Price to Sales Ratio Twelve Trailing Months 19.82
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 71,734,000
Market Capitalization 196,551,160
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.74%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 29.60%
Annual Earnings Growth -136.34%
Reported EPS 12 Trailing Months -0.83
Reported EPS Past Year -0.57
Reported EPS Prior Year -0.18
Net Income Twelve Trailing Months -60,239,000
Net Income Past Year -19,500,000
Net Income Prior Year 53,655,000
Quarterly Revenue Growth YOY -32.10%
5-Year Revenue Growth 3.75%
Operating Margin Twelve Trailing Months -58.00%

Balance Sheet

Total Cash Most Recent Quarter 216,478,000
Total Cash Past Year 267,763,000
Total Cash Prior Year 290,407,000
Net Cash Position Most Recent Quarter 216,478,000
Net Cash Position Past Year 267,763,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 410,338,000
Total Stockholder Equity Prior Year 430,671,000
Total Stockholder Equity Most Recent Quarter 361,980,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -43,649,000
Free Cash Flow Per Share Twelve Trailing Months -0.61
Free Cash Flow Past Year 23,577,000
Free Cash Flow Prior Year 131,280,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.77
RSI 0.00
50-Day SMA 0.00
150-Day SMA 4.66
200-Day SMA 4.66

System

Modified 1/17/2026 12:28:25 AM EST